ENACT - REACT COVID (microbiome signatures)

Start Date

March 2020

Duration

24 months

placeholder.jpg
placeholder_edited.jpg

Title: Study of gut microbiome signatures in COVID-19.


Design: Longitudinal laboratory-based prospective study.


Registration Number: Verona cohort registered on ClinicalTrials.gov


Primary Objective: to assess changes in the gut microbiome composition over time according to disease severity and treatment.


Secondary Objective(s): to find markers of microbiome composition correlated to immunological markers of infections; to assess changes in microbiome according to coinfections.


Interested in collaboration? Contact: Elda Righi (elda.righi@univr.it).


Publications: Submitted

Partners

University of Verona

ID-CARE

  • Elda Righi

  • Evelina Tacconelli

  • Ilaria Dalla Vecchia

  • Lorenza Lambertenghi

  • Nina Auerbach